{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:41:55Z","timestamp":1790606515417,"version":"4.1.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Cancer cachexia (CC) is characterized by weight loss with specifically reduced skeletal muscles and adipose tissues in patients with late-stage cancer. Dihydroartemisinin (DHA), an effective antimalarial derivative of artemisinin, has been demonstrated to have anti-inflammatory and antitumor properties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This study examined the effects of DHA on the Lewis lung carcinoma (LLC)-induced CC mouse model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      DHA treatment significantly increases tumor-free body weight and food intake but decreases serum interleukin-6 level and tumor weight in CC mice. In addition, DHA treatment relieves muscle atrophy and decreases muscle ring finger 1 (\n                      <jats:italic toggle=\"yes\">MuRF1<\/jats:italic>\n                      ) and F-box-only protein 32 (\n                      <jats:italic toggle=\"yes\">Fbx32<\/jats:italic>\n                      ) expressions in CC mice.\n                      <jats:italic toggle=\"yes\">In vitro<\/jats:italic>\n                      , DHA reverses the reduction in myotube formation induced by an LLC-conditioned medium and increases Fbx32 expression in C2C12 mouse myotubular cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our study demonstrated that DHA ameliorates the cachectic state and skeletal muscle atrophy in LLC-induced cachectic mouse models, suggesting its therapeutic potential for CC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_140_24","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T12:03:19Z","timestamp":1736510599000},"page":"2004-2012","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Dihydroartemisinin ameliorates skeletal muscle atrophy in the lung cancer cachexia mouse model"],"prefix":"10.4103","volume":"20","author":[{"given":"Xin","family":"Li","sequence":"first","affiliation":[{"name":"Department of Medical Ultrasound, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, People\u2019s Republic of China"},{"name":"Medical Research Center, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Zhu","sequence":"additional","affiliation":[{"name":"Medical Research Center, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keting","family":"Wen","sequence":"additional","affiliation":[{"name":"Medical Research Center, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Ling","sequence":"additional","affiliation":[{"name":"Medical Research Center, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, People\u2019s Republic of China"},{"name":"Department of Oncology, Affiliated Hospital of Weifang Medical College, Weifang, Shandong, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Huang","sequence":"additional","affiliation":[{"name":"Medical Research Center, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Affiliated Hospital of Weifang Medical College, Weifang, Shandong, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Ultrasound, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"R1-20250110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2613.2012.00812.x","article-title":"Muscle wasting in animal models of severe illness","volume":"93","author":"Holecek","year":"2012","journal-title":"Int J Exp Pathol"},{"key":"R2-20250110","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia:Understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"R3-20250110","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Prim"},{"key":"R4-20250110","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia:A new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"R5-20250110","doi-asserted-by":"crossref","first-page":"893","DOI":"10.4103\/jcrt.JCRT_1762_20","article-title":"Prognostic value of diffuse cancer inflammation index (ALI), serum neutrophil\/lymphocyte (NLR) and platelet\/lymphocyte (PLR) in advanced-stage lung cancer","volume":"20","author":"Ozturk","year":"2024","journal-title":"J Cancer Res Ther"},{"issue":"(Supplement)","key":"R6-20250110","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.4103\/jcrt.JCRT_1533_20","article-title":"Evaluation of quality of life in posttreatment upper aerodigestive tract cancer patients","volume":"19","author":"Sujith","year":"2023","journal-title":"J Cancer Res Ther"},{"issue":"(Suppl 2)","key":"R7-20250110","doi-asserted-by":"crossref","first-page":"S490","DOI":"10.4103\/jcrt.jcrt_2699_22","article-title":"Lung cancer metastasizing to salivary glands:Systematic review","volume":"19","author":"Gupta","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R8-20250110","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia:An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"R9-20250110","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/jcsm.12303","article-title":"Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy","volume":"9","author":"Cerquone Perpetuini","year":"2018","journal-title":"J Cachexia, Sarcopenia Muscle"},{"key":"R10-20250110","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4103\/jcrt.jcrt_733_23","article-title":"E3 ubiquitin-ligase RNF138 may regulate p53 protein expression to regulate the self-renewal and tumorigenicity of glioma stem cells","volume":"19","author":"Chao","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R11-20250110","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/jcsm.12377","article-title":"MyD88 signalling is critical in the development of pancreatic cancer cachexia","volume":"10","author":"Zhu","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R12-20250110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12032-015-0497-y","article-title":"The prognostic role of inflammation and hormones in patients with metastatic cancer with cachexia","volume":"32","author":"Bilir","year":"2015","journal-title":"Med Oncol"},{"key":"R13-20250110","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cyto.2012.10.023","article-title":"Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients","volume":"61","author":"Batista","year":"2013","journal-title":"Cytokine"},{"key":"R14-20250110","first-page":"e26798","article-title":"What role do inflammatory cytokines play in cancer cachexia?","volume":"14","author":"Malla","year":"2022","journal-title":"Cureus"},{"key":"R15-20250110","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fonc.2020.00298","article-title":"Management of cancer cachexia:Attempting to develop new pharmacological agents for new effective therapeutic options","volume":"10","author":"Marceca","year":"2020","journal-title":"Front Oncol"},{"key":"R16-20250110","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3892\/ijmm.2017.3085","article-title":"Anti-angiogenic properties of artemisinin derivatives (Review)","volume":"40","author":"Wei","year":"2017","journal-title":"Int J Molecular Med"},{"key":"R17-20250110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.biopha.2018.01.078","article-title":"Dihydroartemisinin ameliorates sepsis-induced hyperpermeability of glomerular endothelium via up-regulation of occludin expression","volume":"99","author":"Cheng","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"R18-20250110","doi-asserted-by":"crossref","first-page":"10829","DOI":"10.2147\/OTT.S248492","article-title":"Dihydroartemisinin inhibits the proliferation, colony formation and induces ferroptosis of lung cancer cells by inhibiting PRIM2\/SLC7A11 Axis","volume":"13","author":"Yuan","year":"2020","journal-title":"Onco Targets Ther"},{"key":"R19-20250110","doi-asserted-by":"crossref","first-page":"109704","DOI":"10.1016\/j.cbi.2021.109704","article-title":"Dihydroartemisinin mediating PKM2-caspase-8\/3-GSDME axis for pyroptosis in esophageal squamous cell carcinoma","volume":"350","author":"Jiang","year":"2021","journal-title":"Chem Biol Interact"},{"key":"R20-20250110","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.7150\/thno.55939","article-title":"Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer","volume":"11","author":"Bai","year":"2021","journal-title":"Theranostics"},{"key":"R21-20250110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/2141-9248.153609","article-title":"Anticancer effect of AntiMalarial artemisinin compounds","volume":"5","author":"Das","year":"2015","journal-title":"Ann Med Health Sci Res"},{"key":"R22-20250110","first-page":"101","article-title":"Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancer","volume":"27","author":"Wu","year":"2012","journal-title":"Oncol Rep"},{"key":"R23-20250110","doi-asserted-by":"crossref","first-page":"9528","DOI":"10.3892\/mmr.2017.7832","article-title":"Dihydroartemisinin treatment exhibits antitumor effects in glioma cells through induction of apoptosis","volume":"16","author":"Xu","year":"2017","journal-title":"Mol Med Rep"},{"key":"R24-20250110","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.7150\/jca.33704","article-title":"Dihydroartemisinin induces endothelial cell autophagy through suppression of the Akt\/mTOR pathway","volume":"10","author":"Liu","year":"2019","journal-title":"J Cancer"},{"key":"R25-20250110","doi-asserted-by":"crossref","first-page":"117221","DOI":"10.1016\/j.lfs.2019.117221","article-title":"Dihydroartemisinin inhibits endothelial cell tube formation by suppression of the STAT3 signaling pathway","volume":"242","author":"Gao","year":"2020","journal-title":"Life Sci"},{"key":"R26-20250110","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.3892\/etm.2014.1997","article-title":"Dihydroartemisinin inhibits vascular endothelial growth factor-induced endothelial cell migration by a p38 mitogen-activated protein kinase-independent pathway","volume":"8","author":"Guo","year":"2014","journal-title":"Exp Ther Med"},{"key":"R27-20250110","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3892\/ijmm.2015","article-title":"Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway","volume":"35","author":"Dong","year":"2015","journal-title":"Int J Mol Med"},{"key":"R28-20250110","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11011-020-00533-2","article-title":"Dihydroartemisinin ameliorates LPS-induced neuroinflammation by inhibiting the PI3K\/AKT pathway","volume":"35","author":"Gao","year":"2020","journal-title":"Metab Brain Dis"},{"issue":"(Supplement)","key":"R29-20250110","doi-asserted-by":"crossref","first-page":"S305","DOI":"10.4103\/jcrt.JCRT_104_20","article-title":"MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells","volume":"18","author":"Yamana","year":"2022","journal-title":"J Cancer Res Ther"},{"key":"R30-20250110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13395-021-00274-5","article-title":"Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release","volume":"11","author":"Zhou","year":"2021","journal-title":"Skeletal Muscle"},{"key":"R31-20250110","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/cncr.22944","article-title":"A placebo-controlled double blind trial of etanercept for the cancer anorexia\/weight loss syndrome:Results from N00C1 from the North Central Cancer Treatment Group","volume":"110","author":"Jatoi","year":"2007","journal-title":"Cancer"},{"key":"R32-20250110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jcsm.12054","article-title":"Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling","volume":"7","author":"Chen","year":"2016","journal-title":"J Cachexia, Sarcopenia Muscle"},{"key":"R33-20250110","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/jcsm.12710","article-title":"Carnosol and its analogues attenuate muscle atrophy and fat lipolysis induced by cancer cachexia","volume":"12","author":"Lu","year":"2021","journal-title":"J Cachexia, Sarcopenia Muscle"},{"key":"R34-20250110","doi-asserted-by":"crossref","first-page":"15347354231168369","DOI":"10.1177\/15347354231168369","article-title":"Babao dan alleviates cancer cachexia in mice via inhibiting IL-6\/STAT3 signaling pathway","volume":"22","author":"Qiu","year":"2023","journal-title":"Integr Cancer Ther"},{"key":"R35-20250110","first-page":"961","article-title":"Anticancer properties of carnosol:A summary of in vitro and in vivo evidence","volume":"9","author":"O'Neill","year":"2020","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"R36-20250110","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.3892\/ol.2016.5223","article-title":"Dihydroartemisinin transiently activates the JNK\/SAPK signaling pathway in endothelial cells","volume":"12","author":"Dong","year":"2016","journal-title":"Oncology letters"},{"key":"R37-20250110","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3892\/etm.2021.10141","article-title":"Dihydroartemisinin inhibits endothelial cell migration via the TGF-\u03b21\/ALK5\/SMAD2 signaling pathway","volume":"22","author":"Guo","year":"2021","journal-title":"Exp Ther Med"},{"key":"R38-20250110","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1111\/jcmm.13448","article-title":"Dihydroartemisinin up-regulates VE-cadherin expression in human renal glomerular endothelial cells","volume":"22","author":"Li","year":"2018","journal-title":"J Cell Mol Med"},{"key":"R39-20250110","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/jcsm.12851","article-title":"Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole","volume":"13","author":"Liu","year":"2022","journal-title":"J Cachexia, Sarcopenia Muscle"},{"key":"R40-20250110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jcsm.12023","article-title":"Ghrelin prevents tumour- and cisplatin-induced muscle wasting:Characterization of multiple mechanisms involved","volume":"6","author":"Chen","year":"2015","journal-title":"J Cachexia, Sarcopenia Muscle"},{"key":"R41-20250110","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00280-011-1643-7","article-title":"Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-\u03baB pathway","volume":"68","author":"Wang","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"R42-20250110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00280-009-1129-z","article-title":"Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro","volume":"66","author":"Zhou","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"R43-20250110","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R44-20250110","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/SPC.0000000000000091","article-title":"Role of interlekin-6 in cachexia:Therapeutic implications","volume":"8","author":"Narsale","year":"2014","journal-title":"Curr Opinion Support Palliat Care"},{"key":"R45-20250110","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1242\/bio.20136544","article-title":"Characterization of the male ApcMin\/+mouse as a hypogonadism model related to cancer cachexia","volume":"2","author":"White","year":"2013","journal-title":"Biol Open"},{"key":"R46-20250110","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1038\/onc.2016.437","article-title":"Blockade of the IL-6 trans-signalling\/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma","volume":"36","author":"Miller","year":"2017","journal-title":"Oncogene"},{"key":"R47-20250110","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2217\/fon.15.195","article-title":"Muscle wasting as main evidence of energy impairment in cancer cachexia:Future therapeutic approaches","volume":"11","author":"Madeddu","year":"2015","journal-title":"Future Oncol (London, England)"},{"key":"R48-20250110","doi-asserted-by":"crossref","first-page":"39640","DOI":"10.18632\/oncotarget.17387","article-title":"Pantoprazole blocks the JAK2\/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"R49-20250110","first-page":"E469","article-title":"Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1. American journal of physiology","volume":"307","author":"Bodine","year":"2014","journal-title":"Endocrinol Metab"},{"key":"R50-20250110","doi-asserted-by":"crossref","first-page":"18135","DOI":"10.1073\/pnas.0404341102","article-title":"Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I","volume":"101","author":"Kedar","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R51-20250110","first-page":"223","article-title":"C2C12 murine myoblasts as a model of skeletal muscle development:Morpho-functional characterization","volume":"48","author":"Burattini","year":"2004","journal-title":"Eur J Histochem"},{"key":"R52-20250110","doi-asserted-by":"crossref","first-page":"8148","DOI":"10.3390\/ijms23158148","article-title":"Tetrandrine inhibits skeletal muscle differentiation by blocking autophagic flux","volume":"23","author":"Li","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_140_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:39:30Z","timestamp":1787773170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_140_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_140_24","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"2024-01-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}